Using CBPR to Engage Hazardous Drinking Women in the HIV Prevention and Care Continuum (NCT04090723) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Using CBPR to Engage Hazardous Drinking Women in the HIV Prevention and Care Continuum
United States12 participantsStarted 2021-09-14
Plain-language summary
Unhealthy alcohol use among women with and at risk for HIV can interrupt critical steps in the HIV prevention and care continuum, is associated with HIV transmission risk behaviors, and contributes to health disparities. Thus it is critical to accurately identify alcohol use and implement alcohol interventions among women with and at risk for HIV to optimize health outcomes. The proposed pilot study will examine the implementation and effects of a computer delivered brief alcohol intervention with peer navigation/Community Health Worker compared to usual care on alcohol use, linkage to health services, and uptake of HIV prevention practices.
Who can participate
Age range
18 Years – 80 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* At risk and Women with HIV ≥18 years
* Alcohol misuse, defined as \>7 standard drinks per week or \> 3 drinks per occasion in the last three months or AUDIT-C ≥3
* Able to understand English
* Able to read at a 5th grade level.
Additional inclusion criteria for at risk women:
* sex under the influence of alcohol or
* exchanging sex for money or other resources or
* unprotected vaginal or anal sex or illicit drug use in the last 12 months
Exclusion Criteria:
* Pregnant (will be referred immediately to alcohol, mental health, substance use treatment as needed)
* Non-English speaking
* Unable to receive text messages
* Actively psychotic, or otherwise not able to participate in the computer delivered brief intervention.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Intervention Feasibility as assessed by a 4-item scale
Timeframe: 3 months
2
Intervention Acceptability as assessed by a 4-item scale